Cahill Logo

Firm News

Julie Cohen
Director of Marketing and Communications

Cahill Represents Envigo International Holdings in Merger with LabCorp

Date: 04/23/19

Cahill Gordon & Reindel LLP represented Envigo International Holdings, Inc. (Envigo), a leading provider of nonclinical contract research services and research models, in connection with an agreement whereby LabCorp’s (NYSE: LH) Covance Drug Development segment will acquire Envigo’s nonclinical research services business and Envigo’s Research Models Services business will acquire the Covance Research Products business. This will result in Envigo becoming a pure-play research models and services business, while Covance will expand its global nonclinical drug development capabilities.

The Cahill team representing Envigo is led by corporate partners, Kimberly C. Petillo-Décossard, Jonathan A. Schaffzin and Ross E. Sturman, and includes corporate counsel, Donna Bryan, and associates, Joseph F. Rosati, Nikolas X. Rodriguez, David A. Rand, and Yilin (Zoey) Zhu; antitrust partner, Elai Katz, and counsel, Lauren Rackow; environmental associate, Peter J. Gioello; executive compensation and benefits counsel, Mark J. Gelman; intellectual property counsel, Alexander M. Kim; litigation counsel, Gail E. Johnston; real estate counsel, Thomas E. Charbonneau, and associate, Leonardo A. Acevedo; regulatory associate, Peter Mazzone; and tax partner, Craig M. Horowitz, and associate, Samir Kurani.